Autologous blood transfusion in elective cardiac valve operations

Journal of Cardiac Surgery

Volumn 20, Issue 6, 2005, Pages 513-518

  Lewis, Chad E ^a   Hiratzka, Loren F ^b   Woods, Scott E ^c   Hendy, Mary P ^a   Engel, Amy M ^a  

^a GOOD SAMARITAN HOSPITAL   (United States)

^b Cardiac Vascular and Thoracic Surgeons Inc ^*  (United States)

^c Bethesda Hospital   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FRESH FROZEN PLASMA;

ADULT; ALLOGRAFT; ARTICLE; BLOOD AUTOTRANSFUSION; BLOOD DONOR; CASE CONTROL STUDY; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE CLASSIFICATION; ERYTHROCYTE TRANSFUSION; HEART VALVE SURGERY; HUMAN; LENGTH OF STAY; PREOPERATIVE CARE; PROSPECTIVE STUDY;

BLOOD LOSS, SURGICAL; BLOOD TRANSFUSION, AUTOLOGOUS; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; CONFOUNDING FACTORS (EPIDEMIOLOGY); ERYTHROCYTE TRANSFUSION; HEART VALVE DISEASES; HEART VALVE PROSTHESIS IMPLANTATION; HUMANS; PLASMA; PROSPECTIVE STUDIES; SURGICAL PROCEDURES, ELECTIVE; TREATMENT OUTCOME;

EID: 28444449487     PISSN: 08860440     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1540-8191.2005.00137.x     Document Type: Article

References (30)

1. Dodd RY, Notari IV, Stramer SL: Current prevalence and incidence of infectious disease markers and estimated window-period risk in the American Red Cross blood donor program. Transfusion 2002;42:975-979.
2. AuBuchon JP, Birkmeyer JD, Busch MP: Safety of the blood supply in the United States: Opportunities and controversies. Ann Intern Med 1997;127:904-909.
3. Glynn SA, Schreiber GB, Busch MP, et al: Demographic characteristics, unreported risk behaviors, and the prevalence and incidence of viral infections: A comparison of spheresis and whole-blood donors. The Retrovirus Epidemiology Donor Study. Transfusion 1998;38:350-358.
4. Glynn SA, Kleinman SH, Schreiber GB, et al: Trends in incidence and prevalence of major transfusion-transmissible viral infections in US blood donors, 1991 to 1996. The Retrovirus Epidemiology Donor Study (REDS). JAMA 2000;284:229-235.
5. Dodd RY: Germs, gels, and genomes: A personal recollection of 30 years in blood safety testing. In: Stramer SL (ed): Blood Safety in the New Millennium. American Association of Blood Banks, Bethesda, 2001, pp. 97-122.
6. Dodd RY, Stramer SL, Aberle-Grasse J, et al: Risk of hepatitis and retroviral infections among blood donors and introduction of nucleic acid testing (NAT). Dev Biol Stand 2000;102:19-27.
7. Ruel MA, Rubens FD: Non-pharmacological strategies for blood conservation in cardiac surgery. Can J Anesth Suppl 2001;48:4S13-4S23.
8. Laupacis A, Fergusson D: Erythropoietin to minimize perioperative blood transfusion: A systematic review of randomized trials. The International Study of Perioperative Transfusion (ISPOT) Investigators. Transfus Med 1998;8:309-317.
9. Graham ID, Fergusson D, McAuley L, et al: The use of technologies to minimize exposure to perioperative allogeneic blood transfusion in elective surgery. A survey of Canadian hospitals. Int J Technol Assess Health Care 2000;16:228-241.
10. Sowade O, Warnke H, Scigalla P, et al: Avoidance of allogeneic blood transfusions by treatment with epoetin beta (recombinant human erythropoietin) in patients undergoing open-heart surgery. Blood 1997;89:411-418.
11. Sawade O, Ziemer S, Sowade B, et al: The effect of preoperative recombinant human erythropoietin therapy on platelets and hemostasis in patients undergoing cardiac surgery. J Lab Clin Med 1997;129:376-383.
12. Sowade O, Gross J, Sowade B, et al: Evaluation of oxygen availability with oxygen status algorithm in patients undergoing open heart surgery treated with epoetin beta. J Lab Clin Med 1997;129:97-105.
13. D'Ambra MN, Gray RJ, Hillman R, et al: Effect of recombinant human erythropoietin on transfusion risk in coronary bypass patients. Ann Thorac Surg 1997;64:1686-1693.
14. Peters DC, Noble S: Aprotinin. An update of its pharmacology and therapeutic use in open heart surgery and coronary artery bypass surgery. Drugs 1999;57:233-260.
15. Fremes SE, Wong BI, Lee E, et al: Meta-analysis of prophylactic drug treatment in the prevention of postoperative bleeding. Ann Thorac Surg 1994;58:1580-1588.
16. Laupacis A, Fergusson D: Drugs to minimize perioperative blood loss in cardiac surgery: Meta-analyses using perioperative blood transfusion as the outcome. The International Study of Peri-operative Transfusion (ISPOT) Investigators. Anesth Analg 1997;85:1258-1267.
17. Hardy JF: Pharmacological strategies for blood conservation in cardiac surgery: Erythropoietin and antifibrinolytics. Can J Anesth Suppl 2001;48:4S24-4S31.
18. Owings DV, Kruskall MS, Thurer RL, et al: Autologous blood donations prior to elective cardiac surgery. Safety and effect on subsequent blood use. JAMA 1989;262:1963-1968.
19. Britton LW, Eastlund DT, Dziuban SW, et al: Predonated autologous blood use in elective cardiac surgery. Ann Thorac Surg 1989;47:529-532.
20. Love TR, Hendren WG, O'Keefe DD, et al: Transfusion of predonated autologous blood in elective cardiac surgery. Ann Thorac Surg 1987;43:508-512.
21. Bowden RA: Transfusion-transmitted cytomegalovirus infection. Hematol Oncol Clin North Am 1995;9:155-166.
22. Dodd RY: Transfusion-transmitted hepatitis virus infection. Hematol Oncol Clin North Am 1995;9:137-154.
23. Williams AE, Sullivan MT: Transfusion-transmitted hepatitis virus infection. Hematol Oncol Clin North Am 1995;9:115-136.
24. Krishnan LA, Brecher ME: Transfusion-transmitted bacterial infection. Hematol Oncol Clin North Am 1995;9:167-185.
25. Glynn Sa, Kleinman SH, Schreiber GB, et al: Trends in incidence and prevalence of major transfusion-transmissible viral infections in US blood donors, 1991-1996. Retrovirus Epidemiology Donor Study (REDS). JAMA 2000;284:220-235.
26. Greenburg AG, Kim HW, Hemolink Study Group: Use of an oxygen therapeutic as an adjunct to intraoperative autologous donation to reduce transfusion requirements in patients undergoing coronary artery bypass grafting. J Am Coll Surg 2004;198:373-383.
27. Tempe D, Bajwa R, Cooper A, et al: Blood conservation in small adults undergoing valve surgery. J Cardiothorac Vasc Anesth 1996;10:502-506.
28. Dalrymple-Hay MJR, Dawkins S, Pack L, et al: Autotransfusion decreases blood usage following cardiac surgery - A prospective randomized trial. Cardiovasc Surg 2001;9:184-187.
29. Wong JCL, Torella F, Haynes SL, et al: Autologous vs. allogeneic transfusion in aortic surgery. A multicenter randomized clinical trial. Ann Surg 2002;235:145-151.
30. Kasper SM, Ellering J, Stachwitz P, et al: All adverse events in autologous blood donors with cardiac disease are not necessarily caused by blood donation. Transfusion 1998;38:669-673.